BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Jan. 4, 2023-- SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023 , at 8:15 a.m.
